CLINICAL TRIALS PROFILE FOR MYOBLOC
✉ Email this page to a colleague
All Clinical Trials for MYOBLOC
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00125203 ↗ | Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS) | Completed | ALS Association | Phase 2/Phase 3 | 2003-07-01 | The purpose of this study is to determine the safety and efficacy of Myobloc in ALS patients who are having excessive drooling. The primary goal of the study is to determine if the patient perceives a benefit from the Myobloc in controlling excessive drooling. |
NCT00125203 ↗ | Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS) | Completed | Carolinas MDA Neuromuscular/ALS Center-Carolinas Medical System | Phase 2/Phase 3 | 2003-07-01 | The purpose of this study is to determine the safety and efficacy of Myobloc in ALS patients who are having excessive drooling. The primary goal of the study is to determine if the patient perceives a benefit from the Myobloc in controlling excessive drooling. |
NCT00125203 ↗ | Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS) | Completed | University of Kansas | Phase 2/Phase 3 | 2003-07-01 | The purpose of this study is to determine the safety and efficacy of Myobloc in ALS patients who are having excessive drooling. The primary goal of the study is to determine if the patient perceives a benefit from the Myobloc in controlling excessive drooling. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for MYOBLOC
Condition Name
Clinical Trial Locations for MYOBLOC
Trials by Country
Clinical Trial Progress for MYOBLOC
Clinical Trial Phase
Clinical Trial Sponsors for MYOBLOC
Sponsor Name